$IVVD 8-K SEC Filings

Filed On	Filing
29 Sep 2026	8-K: Other Events Invivyd Announces Positive Topline Results from LIBERTY Phase 3 Study Demonstrating VYD2311 Safety and Tolerability Superior to mRNA-based COVID-19 Vaccine; Announces Regulatory Submission Plans for VYD2311
01 Sep 2026	8-K: Departure/Election of Directors or Officers; Compensation; Other Events
13 Aug 2026	8-K: Results of Operations and Financial Condition
24 Jul 2026	8-K: Notice of Delisting or Failure to Satisfy a Listing Rule
06 Jul 2026	8-K: Other Events
19 May 2026	8-K: Submission of Matters to a Vote of Security Holders
14 May 2026	8-K: Results of Operations and Financial Condition; Other Events
09 Apr 2026	8-K: Other Events
05 Mar 2026	8-K: Results of Operations and Financial Condition; Other Events
08 Jan 2026	8-K: Results of Operations and Financial Condition; Other Events
23 Dec 2025	8-K: Other Events
24 Nov 2025	8-K: Other Events
19 Nov 2025	8-K: Entry into a Material Definitive Agreement; Other Events
06 Nov 2025	8-K: Results of Operations and Financial Condition; Other Events
30 Oct 2025	8-K: Other Events
06 Oct 2025	8-K: Other Events
24 Sep 2025	8-K: Departure/Election of Directors or Officers; Compensation; Regulation FD Disclosure +1 more
22 Aug 2025	8-K: Entry into a Material Definitive Agreement; Other Events
14 Aug 2025	8-K: Results of Operations and Financial Condition; Other Events
02 Jul 2025	8-K: Other Events

Comments